Data / Form D filings / Kaigene, Inc.
Kaigene, Inc.: Form D filing
Kaigene, Inc., a biotechnology company in Rockville, MD, filed a Form D with the SEC in 2026. The latest, on October 14, 2026, reports $55 million sold of a $73.4 million offering to 22 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 9800 MEDICAL CENTER DRIVE A110, Rockville, MD, 20850
- Phone
- (301) 655-8569
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2021
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1919055
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Oct 14 | New notice | $73,350,000 | $54,958,229 | $18,391,771 | 22 | Sep 30 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Minjae Shin | Executive Officer, Director | |
| Jihoon Park | Executive Officer | |
| Kyunghyun Min | Director | |
| Tae Heum Jeong | Director |
Other biotechnology companies in Maryland that filed recently
- Templar Nova, Inc. $7 million · Oct 7
- Monocacy Therapeutics Inc. $25,000 · Oct 7
Every Form D from the week of Oct 12 · All recent filings in Maryland · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Kaigene, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.